Veracyte (VCYT) Tops Q2 EPS by 12c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $55.1 million versus the consensus estimate of $48.06 million.

GUIDANCE:

Veracyte sees FY2021 revenue of $200-208 million, versus the consensus of $197.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell